17,261 trials
B-cell Lymphoma · Chronic Lymphocytic Leukaemia · Waldenström Macroglobulinemia
Primary: Documenting Adverse Events (AEs), Serious Adverse Events (SAEs), Dose Limiting Toxicities (DLTs) (Graded According to NCI-CTCAE Version 4.02) and Laboratory Parameters…
Diabetic Macular Edema · Hard Lipid Exudates
Primary: Best Corrected Visual Acuity as Measured by ETDRS at 6 and 12 Months — 78; 73.92; 77.92; 74.83 letters read correctly
Brain Tumors
Primary: Event-free Survival (EFS)
Dry Eye
Primary: Change From Baseline in Drop Discomfort Post Dose Instillation on Day 1 — 7.9; 3.5 mm — p=0.1491
Amyotrophic Lateral Sclerosis
Primary: Part 1: Number of Participants With Potentially Clinically Significant Hematology Results by Treatment Group — 0; 0; 0; 0 Participants
Limb-girdle Muscular Dystrophy · Becker Muscular Dystrophy
Primary: Fasting Glucose — 93; 102 mg/dL
Lyme Borreliosis
Primary: GMTs for IgG Against Each OspA Serotype — 278.5; 274.7; 21.0; 545.2 Units per milliliter (U/mL)
Low Back Pain
Primary: Change From Baseline in Daily Average Low Back Pain Intensity (LBPI) Score at Week 16: Baseline Observation Carried Forward (BOCF) — 6.71; 6.62; 6.57; 6.74 units on a…
Neoplasms
Primary: Stage 1: Cohort 1: Objective Response Rate (ORR) — 56.3 Percentage of participants
Covid19 · Pneumonia, Viral
Primary: Count of White Blood Cells (WBC) After 99mTc-pertechnetate Aerosol Inhalation for Adverse Events Monitoring as Evaluation Safety of This Procedure in Patients With…
Malignant Solid Tumor
Primary: Length of Exposure to NKTR-102 — 139.0; 33.0; 126.0; 21.0 days
Tympanomastoid Surgery · Cochlear Implant · Mastoidectomy
Primary: Average Observer-Rated Patient Pain Scores — 2; 1.9 units on a scale
Endometriosis-related Pain
Primary: Change From Baseline in Average Daily Pelvic Pain Score During Treatment Cycle 2 — -2.2; -1.7 Scores on a Scale — p=0.066
Glioblastoma · Brain Tumor, Recurrent
Primary: Progression-free Survival (PFS) at Six Months (PFS6m) — 26; 4; 16; 1 Participants
Acute Biphenotypic Leukemia · Acute Lymphoblastic Leukemia in Remission · Acute Myeloid Leukemia in Remission
Primary: Time to Neutrophil Engraftment — 20.0; 22.0 days